MedTrace Logo

Citicoline as Neuroprotector in Neonates Exposed to Hypoxia

NCT03949049 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2019-05-29

No results posted yet for this study

Summary

Citicoline as neuroprotector in neonates exposed to hypoxia: A randomized controlled trial

Conditions

  • Neonatal Hypoxia

Interventions

DRUG

Citicoline

Citacoline as neuroprotector

OTHER

Placebo

placebo group

Sponsors & Collaborators

  • Sherief Abd-Elsalam

    lead OTHER

Principal Investigators

  • Abeer Salamah, Lecturer · Pediatrics department - Kafr-Elsheikh university

  • May R Elsheikh, Lecturer · Pediatrics department - Tanta university

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Max Age
1 Month
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-01
Primary Completion
2029-12-01
Completion
2029-12-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03949049 on ClinicalTrials.gov